ProfileGDS5822 / ILMN_3033533
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 93% 95% 94% 95% 94% 93% 95% 95% 92% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1779.493
GSM1276600PDAC Late Ablation Control 21207.695
GSM1276601PDAC Late Ablation Control 3111594
GSM1276602PDAC Late Ablation 11028.195
GSM1276603PDAC Late Ablation 2921.594
GSM1276604PDAC Late Ablation 3895.193
GSM1303940PDAC Late Ablation_anti-CTLA4 11235.295
GSM1303941PDAC Late Ablation_anti-CTLA4 21314.895
GSM1303942PDAC Late Ablation_anti-CTLA4 3844.892